IL6 and Alzheimer disease: Neuroinflammation is involved in AD pathologies and progression, and insulin deficiency induced by STZ promotes neuroinflammation and glial activation [14], which increases the levels of pro-inflammatory cytokines, including IL-6 and TNF-α [34].